Exelixis (EXEL) Tops Q1 EPS by 10c, provides guidance
Tweet
Share
E-mailGet Alerts EXEL Hot Sheet
Price: $58.36 -0.22%
EPS Growth %: +14.1%
Financial Fact:
Research and development: 22.98M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: +14.1%
Financial Fact:
Research and development: 22.98M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Exelixis (NASDAQ: EXEL) reported Q1 EPS of $0.87, $0.10 better than the analyst estimate of $0.77. Revenue for the quarter came in at $610.8 million versus the consensus estimate of $608.95 million.
GUIDANCE:
Exelixis sees FY2026 revenue of $2.525-2.625 billion, versus the consensus of $2.583 billion.
For earnings history and earnings-related data on Exelixis (EXEL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. and Denmark close in on a Greenland deal - Reuters
- Nscale files for IPO, seeks NYSE listing under ticker NSCL
- Accenture and Anthropic partner on AI safety evaluation team
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
